Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 10Ovarian Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Lung Neoplasms 3Carcinoma, Ovarian Epithelial 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Rectal Neoplasms 2Melanoma 2Liver Neoplasms 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Urethral Neoplasms 1Tobacco Use Disorder 1Recurrence 1Precancerous Conditions 1Pathologic Complete Response 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasms 1Neoplasm Metastasis 1Kidney Neoplasms 1Hirschsprung Disease 1Glioma 1Ganglion Cysts 1Gallbladder Neoplasms 1Endometrial Neoplasms 1

Interventions

Temozolomide 11Radiotherapy 10Cisplatin 4Carmustine 4Vincristine 3Surgical Procedures, Operative 3Methotrexate 3Lomustine 3Chlorotoxin 3Carboplatin 3Thiotepa 2Etoposide 2Cyclophosphamide 2Chemotherapy, Adjuvant 2Amplified Fragment Length Polymorphism Analysis 2lonafarnib 1interleukin-4-Pseudomonas exotoxin 1Verteporfin 1Valproic Acid 1Tranexamic Acid 1Tf-CRM107 1Tamoxifen 1Procarbazine 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Neoadjuvant Therapy 1Metformin 1Metabolism 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Astrocytoma × Immunohistochemistry × Clear all
NCT00360945 2013-09-17

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

National Cancer Institute (NCI)

Phase 2 Unknown
87 enrolled
CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡